Abstract
Entry motion sickness (EMS) affects crewmembers upon return to Earth following extended adaptation to microgravity. Anticholinergic pharmaceuticals (e.g., Meclizine) are often taken prior to landing; however, they have operationally adverse side effects (e.g., drowsiness). There is a need to develop non-pharmaceutical countermeasures to EMS. We assessed the efficacy of a technological countermeasure providing external visual cues following splashdown, where otherwise only nauseogenic internal cabin visual references are available. Our countermeasure provided motion-congruent visual cues of an Earth-fixed scene in virtual reality, which was compared to a control condition with a head-fixed fixation point in virtual reality in a between-subject design with 15 subjects in each group. We tested the countermeasure’s effectiveness at mitigating motion sickness symptoms at the end of a ground-based reentry analog: approximately 1 h of 2Gx centrifugation followed by up to 1 h of wave-like motion. Secondarily, we explored differences in vestibular-mediated balance performance between the two conditions. While Motion Sickness Questionnaire outcomes did not differ detectably between groups, we found significantly better survival rates (with dropout dictated by reporting moderate nausea consecutively over 2 min) in the visual countermeasure group than the control group (79% survival vs. 33%, t(14) = 2.50, p = 0.027). Following the reentry analogs, subjects demonstrated significantly higher sway prior to recovery (p = 0.0004), which did not differ between control and countermeasure groups. These results imply that providing motion-congruent visual cues may be an effective mean for curbing the development of moderate nausea and increasing comfort following future space missions.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Significance of spaceflight driven motion sickness
The emergence of deep space mission objectives and commercial flights to low Earth orbit have sparked a renewed concern with crew motion sickness resulting from spaceflight gravity transitions. Most commonly characterized by varied symptomology resulting from real or apparent motion (Lackner 2014), motion sickness may manifest in humans as severe discomfort, repeated bouts of vomiting, and even prolonged incapacitation when venturing to and from space (Lackner and DiZio 2006; Thornton and Bonato 2013).
Historically affecting 60–80% of astronauts (Heer and Paloski 2006), ‘space motion sickness’ (SMS) (also referred to as space adaptation syndrome) occurs upon transitioning to a microgravity environment from Earth gravity. This mode of motion sickness is thought to arise due to a modified gravitational stimulus, resulting in persistent unexpected sensory cues from graviceptors, particularly the otoliths (Lackner and Graybiel 1987). This explanation of SMS is consistent with sensory conflict theory of motion sickness in general (i.e., the difference between the peripherally ‘sensed’ and centrally ‘expected’ vestibular cues) (Oman 1982, 1990; Reason and Brand 1975), and neural correlates of sensory conflict have been observed in the brainstem and cerebellum (Oman and Cullen 2014).
The sensory conflict experienced in space is theorized to drive adaptation through reinterpretation of the internal model used to process sensory cues (Allred et al. 2023; Kravets et al. 2021) and reweighting of different sensory modalities. Evidence for reweighting has been previously observed in functional MRIs of astronauts and cosmonauts after returning from orbit (Hupfeld et al. 2022; Pechenkova et al. 2019) wherein brain regions associated with visual, somatosensory, proprioceptive, and vestibular sensing change in terms of activation or functional connection when comparing pre- to post-flight values. This conflict-driven adaptation also occurs when returning to Earth from microgravity where crewmembers experience motion sickness during readaptation to Earth 1 g (Gorgiladze and Brianov 1989). Coined ‘entry motion sickness (EMS)’, symptoms arising from this mode of motion sickness are likely to be exacerbated by the passive motions experienced by the crew during splashdowns (specifically with the utilization of the SpaceX Dragon and NASA Orion capsules).
Because SMS and EMS pose significant operational and performance decrements to crewmembers in the first days following a gravity transition (Ortega et al. 2019), effective countermeasures to these modes of motion sickness must be developed to improve crew health and performance during future NASA exploration class missions. Such countermeasures may also be leveraged to provide more tolerable experiences for commercial space travelers.
Existing countermeasures
Currently, pharmaceutical countermeasures such as the administration of promethazine or scopolamine are utilized with varying degrees of success (Bagian 1991; Bagian and Ward 1994; Davis et al. 1993a, b; Davis et al. 1993a, b; Graybiel and Lackner 1987) to either prevent, delay, or ameliorate motion sickness symptoms following gravity transitions (Lackner and DiZio 2006). Due to the delay in effectiveness of orally administered drugs after the onset of motion sickness symptoms, these drugs can also be administered parenterally; promethazine can be injected (Davis et al. 1993a, b) and intranasal scopolamine is currently in development (Beltran et al. 2022). The most commonly administered post-flight treatment, meclizine, is often taken prophylactically before landing (Lee et al. 2020).
However, many anticholinergic pharmaceutics have unwanted side-effects including drowsiness and operational performance degradation (Cowings et al. 2000; Lucot 1998; Wood et al. 1990) at current dosages and occur following administration, during which mission critical operational tasks (e.g., vehicle egress) are typically necessary. Additionally, pharmaceutical shelf-life and long-term stability may prove inadequate for long-duration deep-space missions.
Given the limitations of these countermeasures, there exists a need to develop non-pharmaceutical, or even technological, countermeasures to SMS and EMS. In the terrestrial environment, existing works have found motion sickness symptoms to be affected by non-pharmaceutical stimuli, which may provide avenues of preventing or attenuating symptoms. Looking out the window effectively reduces carsickness (Griffin and Newman 2004; Perrin et al. 2013; Schmidt et al. 2020; Turner 1999), and sailors have historically relied on going on deck and viewing the horizon to ameliorate seasickness (Gupta et al. 2021; Stoffregen et al. 2013).
In studying seasickness using a ship motion simulator, motion sickness was found to be alleviated by providing subjects with an Earth-fixed visual scene, with increasing sickness symptoms observed in the no visual cues (blindfolded in the dark) and inside cabin-view conditions, respectively (Bos et al. 2005). Further, apparent motion driven by visual sensory information that is incongruent with actual motion is known to induce motion sickness (this mode of motion sickness is alternatively referred to as simulator or cybersickness) (Bos et al. 2022; Davis et al. 2014; Kennedy et al. 1993). Together, these findings indicate the nauseogenic nature of incongruent visual and vestibular cueing. This aligns with sensory conflict theory predictions that visual sensory information modifies the central expectation of vestibular cues, and thus incongruent cross-sensory information will lead to sensory conflict driven motion sickness. Sensory conflict theory provides insight into potential avenues for the attenuation of nausea from motion sickness by providing a motion-congruent visual scene. Specifically, that visual cues could help modify the centrally expected vestibular measurements, such that the central expectation more closely matches reality. This could result in less motion sickness-inducing conflict with the peripherally sensed vestibular measurements.
Apart from this modulation, reliable, motion-congruent visual cues may result in more rapid centrally driven vestibular adaptation following a modification of vestibular information (Héroux et al. 2015) (e.g., following a gravity transition). Because the maladapted state is partially responsible for the onset and development of motion sickness (in conjunction with passively experienced motions), expediting (re)adaptation may contribute to motion sickness mitigation.
Currently, neither natural nor virtual external visual cues are available to crewmembers in the capsule environment during and following splashdown, and visual information is restricted to an unhelpful inside cabin-view, which provides cues in conflict with a natural outside view. Based on our current understanding of how visual cues impact the onset and development of motion sickness symptoms, we hypothesize that EMS symptoms will be reduced by administering an Earth-fixed (i.e., motion-congruent) visual scene to crewmembers prior to capsule egress.
Objectives
This study aims to quantify the efficacy of providing visual cues of self-motion for individuals experiencing wave-like motion following a gravity transition in order to reduce motion sickness incidence and severity and mitigate sensorimotor impairment. Primarily, we hypothesized that—when preceded by a gravity transition paradigm (approximately 1 h in duration)—the administration of a motion-congruent, Earth-fixed virtual visual scene during a capsule wave-like motion paradigm would result in less severe motion sickness symptoms compared to a control condition (a head-fixed visual fixation point). Secondarily, we hypothesized that, following the wave-like motion paradigm, the visual scene condition would result in better vestibular-mediated balance performance compared to the control condition.
Methods
Astronauts returning from microgravity undergo a gravity transition followed by sea state motion during water landings. To simulate this experience, we employed ground-based analogs. In summary, our Human Eccentric Rotator Device (HERD, Fig. 1a) was used to simulate gravity transitions using the Sickness Induced by Centrifugation (SIC) paradigm, and wave-like motion was simulated using the Tilt Translation Sled (TTS, Fig. 1b). Both motion devices are located at the University of Colorado, Boulder. The Meta Quest 2 virtual reality (VR) headset was used to provide visual cues congruent with the wave-like motion. The scenes displayed on the headset were developed and controlled with the Unity game-engine development platform.
During and after the wave-like motion, motion sickness symptoms and anxiety progression were recorded through subjective verbal reporting. Standing balance before centrifugation, immediately after the wave-like motion, and following recovery was assessed using modified Romberg balance testing and an inertial measurement unit (IMU).
Sickness induced by centrifugation paradigm
The SIC paradigm posits that prolonged exposure to hyper-gravity using centrifugation is effective at replicating symptoms of space motion sickness as well as postural instabilities and gait destabilization (Albery and Martin 1996; Bles et al. 1996, 1997; Bles and de Graaf 1993; Groen et al. 1996; Nooij et al. 2005, 2007, 2008; Nooij and Bos 2007; Ockels et al. 1990). The severity of symptoms and the recovery time are dependent on the force and duration of centrifugation as characterized by Nooij and Bos, 2007. Because centrifugation during the SIC paradigm is thought to induce a reinterpretation of sensory cues from the graviceptors in the presence of a modified net gravito-inertial force, SIC represents an effective existing ground-based analog for simulating motion sickness and sensorimotor impairment following a gravity transition. SIC has been used extensively to replicate the transition from 1G on Earth to 0G in orbit (Albery and Martin 1996; Bles et al. 1997; Groen et al. 1996; Nooij et al. 2005, 2007; Nooij and Bos 2007; Ockels et al. 1990). To date, there has been no study mapping duration of spaceflight to SIC duration in terms of EMS symptoms.
The HERD is a short-radius centrifuge (9 feet, or 2.74 m) shown in Fig. 1a. One arm of the HERD centrifuge has a “bed” tilted outward 30 degrees from the vertical such that subjects experience 2G hyper-gravity in the head-centered negative x-direction (i.e., “eyeballs in”). Subjects are secured to the padded “bed” using a five-point harness and shoulder supports, and a headrest. The headrest has thick cushioning on both sides of the subject’s head to dissuade roll, pitch, and yaw head rotations, preventing the Coriolis cross-coupling illusion during centrifugation (Bretl et al. 2019; Bretl and Clark 2020, 2022). The test was performed in the dark with the subject’s eyes closed to prevent dizziness due to any light leaking into the room. The foot plate of the HERD was adjusted such that the radius of the subject’s head was at 104 in (2.64 m) and a rotation rate of 24 RPM could be used to generate 2Gx at the subject’s eyes for each participant. Spin-up occurred incrementally such that subjects could comfortably adjust to different levels of centrifugation prior to reaching 2Gx. Due to the changing direction of the gravito-inertial force (GIF, or f) vector from Earth-vertical to 2Gx, and the bed’s mostly upright, fixed position, subjects reliably noted the sensation of falling/pitch tilting backwards as they spun up. Hand holds were provided to mitigate the perceived instability caused by this sensation.
Subjects were exposed to 2Gx on the HERD for 56 min plus spin-up and spin-down time. On average, spin-up took a total of six minutes and spin-down took two minutes. This hyper-gravity exposure was expected to generate mild to moderate SIC symptoms (when followed by head motions) according to Nooij and Bos, 2007, who tested the effects of SIC at 2Gx for 45 min and 90 min. Immediately following SIC on the HERD, subjects were transferred to the TTS via a wheelchair with their head restrained to avoid provocative head tilts during transit.
Wave-like motion
Subjects were exposed to wave-like motion using the TTS for up to an hour. The TTS is a motion device that can perform roll tilt and lateral (i.e., Earth-horizontal) translation along a linear track (Fig. 1b). We developed a wave-like motion profile by analyzing the energy spectra of Coastal Data Information Program (CDIP) Station 067—a buoy located roughly 65 miles off the coast of Southern California and a candidate site for future Orion capsule recoveries. To capture the expected sea-state during recovery, buoy data was extracted during NASA’s Underway Recovery Test-7. Significant wave height during the test was 1.02 m on average which is a three on the WMO Sea State Code, or a slight sea state.
Energy density data from the buoy during a 12-h window beginning at 1100 UTC on October 31, 2018 was parsed for every half hour and summated. This summation was then converted into a cumulative density function by normalizing it by the maximum energy amplitude, and ten frequencies and their corresponding normalized amplitudes were randomly selected using this distribution (range: 0.055–0.23 Hz) to generate roll-tilt and lateral translation sum-of-sines profiles. Incorporating the semi-coupled nature of waves, eight of these frequencies were used for the translation profile while two additional frequencies were randomly selected to be used for tilt. A random phase-shift was also used with each wave to mimic the randomness of the ocean sea state. The maximum tilt amplitude was scaled to 5 degrees and the maximum translation was scaled to 0.75 m. These values were selected after exploratory pilot testing found them to sufficient to produce motion sickness to varying degrees across individuals. Finally, four-second ramp up and ramp down profiles were added by using an 8th order polynomial spline to fit the profiles to initial zero-values for position, velocity, and acceleration. The profiles were set to be 15 min long and were repeated four times to accomplish a full hour of motion.
Subjects were strapped into the TTS using a five-point harness, and an adjustable head restraint was employed to secure subjects’ heads. Subjects underwent wave-like motion for up to an hour (dependent on stopping criteria, discussed below), followed by another hour of recovery sitting with eyes open on a stool in an illuminated lab space. Two-way audio communication was available between the subject and operators during both the HERD and TTS protocols. Further, the subject was monitored via an infrared camera and both subject and operators were provided with buttons to halt motion.
Independent variables
To quantify the efficacy of visual cues at mitigating motion sickness, a between-subject experimental design was implemented with two experimental groups: a visual countermeasure group and a control group. The visual countermeasure group had congruent visual cues of Earth-fixed motion available during the wave-like motion paradigm while the control group was provided with a head-fixed visual fixation point. Both scenes were displayed using the Meta Quest 2 VR headset. The visual countermeasure scene consisted of a forested area with trees for rich references of verticality and people to help provide an approximate reference of scale for perceiving lateral linear translation. The scene moved opposite the direction of subject movement, generating veridical cues of self-motion (e.g., as the subject tilted 5 degrees, the VR scene tilted 5 degrees in the opposite direction from the subject’s perspective, as it would in a naturalistic visual scene). Examples of this scene and the result of subject movement are shown in Fig. 2. The control scene consisted of a black background with a white fixation point. The fixation point did not move across the display, regardless of subject motion.
The headset brightness was fixed regardless of experimental group. Subjects were instructed to size the headset comfortably for themselves. Interpupillary distance (IPD) was measured using either EyeMeasure (iOS) or GlassesOn (Android), and then set to the closest value available on the Quest 2.
Dependent variables
Subjective data consisting of motion sickness and anxiety scoring was the primary metric collected during this study. Motion sickness scores were collected using a Motion Sickness Questionnaire (MSQ) (Kennedy et al. 1993; B. D. Lawson 2014a, b) every five minutes during and after wave-like motion. The full MSQ consists of 28 symptoms associated with motion sickness and asks the subject to rate each symptom on a scale of ‘none’, ‘slight’, ‘moderate’, and ‘severe’. An ordinal score was derived from these ratings by converting them to a scale of 0–3 respectively and summing the values for all symptoms at each time point. Thus, the lowest level of motion sickness on the scale is 0, while higher numbers correspond to more severe motion sickness. In theory, this results in a maximum score of 84; however, the antithetical nature of many of the symptoms (e.g., “increased appetite?” and “decreased appetite?”) makes it unlikely that this could ever be achieved. To avoid confusion in the interpretation of the symptom definitions, subjects were asked if they required clarification on any of the 28 MSQ symptom definitions prior to the experiment and were given definitions consistent with B. D. Lawson 2014a, b supplemented with Oxford Languages 2022 (Oxford Languages was used for symptom definitions not explicitly defined by Lawson). The rating scale itself was entirely subjective.
To further investigate particular symptoms within the MSQ, we considered grouping questions in categories. Cha et al 2021 sorted the symptoms of the MSQ into six categories: gastrointestinal disturbance, thermoregulatory disruption, alterations in arousal, dizziness/vertigo, ocular, and general (Cha et al. 2021). Being of specific interest to this study, we divided the MSQ scores into subcategories based on gastrointestinal disturbance (GI), alterations in arousal (sopite), and ocular symptoms.
GI disturbance includes symptoms such as stomach awareness, increased or decreased appetite, nausea, and vomiting. It represents the classical symptoms that people most often associate with motion sickness. Sopite syndrome is a response to motion sickness that is categorized by apathy, lethargy, and the inability to concentrate (Graybiel and Knepton 1976; Lawson and Mead 1998). However, sopite symptoms are not exclusive to motion sickness and have a notably different time course than traditional GI disturbance symptoms (Lawson and Mead 1998), often starting prior to nausea and extending past when nausea subsides. Ocular symptoms include the presence of headaches, eyestrain, and difficulty focusing. It is expected that these symptoms are impacted the most by the presence of the VR headset, hence requiring both experimental groups to wear it and keeping the headset brightness constant.
To track subjects’ physical wellbeing during centrifugation, they were asked to rate their ‘general discomfort’ and ‘nausea’ on a scale of ‘none’, ‘slight’, ‘moderate’, and ‘severe’ every five minutes. During wave-like motion, these questions were asked every minute. A stopping criterion was established to prevent emesis during wave-like motion: if subjects rated moderate nausea for two consecutive check-ins (i.e., separated by 1 min), the wave-like motion stopped early.
In addition to tracking motion sickness, we collected state anxiety scores at the same intervals as the full MSQ. Previous studies have found correlations between the development of state anxiety and motion sickness (Stelling et al. 2021), suggesting it would be a useful metric. This connection between anxiety and motion sickness may be related to a potential link between the emotional and vestibular neural networks wherein mental and physical mobilization for action occur along the same mental pathways (Clément et al. 2020). Anxiety was scored using a six-question modified State Trait Anxiety Inventory (STAI) (Marteau and Bekker 1992) which asks subjects to rate declarative statements about their mental wellbeing on a scale of ‘not at all’, ‘somewhat’, ‘moderately so’, and ‘very much so.’ This modified STAI focused on state anxiety which refers to feelings in the moment, rather than general anxiety. As is typical, statements were rated on a scale of 1–4 with the highest number being associated with the worst feeling. Similarly, these numbers are summated for all statements at each time point resulting in a minimum STAI of 6 and a maximum of 24. Every five minutes, the subjects scored the full MSQ and the STAI verbally. This continued at the same frequencies throughout the recovery period as well.
Objective data regarding subject sensorimotor impairment was collected as a secondary metric using the Modified Romberg balance test (Agrawal et al. 2011; Bermúdez Rey et al. 2017), specifically ‘condition 4’ focused on isolating vestibular-mediated contributions. For this, subjects were tasked with balancing on a foam mat with their arms crossed, feet together, and eyes closed for 30 s. Failure criteria included uncrossing arms, separating feet, opening eyes, or otherwise losing balance and requiring stabilizing support from test conductors. These trials were performed eight times each at three different points throughout the experiment. A baseline was taken prior to centrifugation, another set was performed after wave-like motion, and a final set after the hour of recovery following wave-like motion. Pass/fail metrics were collected as well as acceleration and gyroscope sway data sampled at 25 Hz from an inertial measurement unit (IMU) positioned on the subject’s central lower back. Sway was characterized as the inertial XY-plane (perpendicular to gravity) RMS of linear acceleration during modified Romberg trial prior to completion or failure.. Prior to the first set of trials, subjects were incremented through a series of easier tasks where they were instructed to balance on solid ground and/or with their eyes open for 30 s. Subjects only performed these tasks once, resulting in three practice tasks before the first set of eight full balance trials.
Experimental design
This study used a between-subject design where experimental groups were balanced by sex and motion sickness susceptibility such that the mean and standard deviation of the Short-Form Motion Sickness Susceptibility Questionnaire (MSSQ) percentile scores were statistically equivalent while maintaining a similar number of female subjects. The MSSQ (Golding 1998, 2006) is a commonly used (Bretl et al. 2019; Bretl and Clark 2020; Irmak et al. 2021) questionnaire that rates subject susceptibility to terrestrial motion sickness as a population percentile based on their history with terrestrial motion sickness. Potential subjects with MSSQ scores in the outer 5th percentiles were excluded from the study to pre-emptively remove outliers. While the MSSQ was not designed to capture susceptibility to non-terrestrial forms of motion sickness, it has been shown to effectively predict sickness scoring during parabolic flights (Golding et al. 2017) and therefore may be extendable to SMS and EMS.
Subject recruitment was primarily done via flyers posted in the laboratory building, yielding a cohort of mostly college-aged engineering students.
Participants
There were 30 total participants across the two experimental groups (age = 23.4 ± 3.5 years, female = 11, MSSQ = 38.4 ± 21.1%) with 15 subjects in each. The control group (female = 5, age = 23.2 ± 3.6 years, MSSQ = 38.3 ± 19.5%) was provided the fixation point while the visual countermeasure group (female = 6, age = 23.5 ± 3.5 years, MSSQ = 40.6 ± 24.0%) was provided accurate visual cues. A graphical representation of the spread of MSSQ scores is available in Fig. 3. Wilcoxon Rank Sum tests for independent samples confirmed that the two groups were not from significantly different populations in terms of their past susceptibility to motion sickness (W = 104, p = 0.74), their sickness score prior to wave-like motion (W = 98.5, p = 0.57), nor their state anxiety prior to wave-like motion (W = 119.5, p = 0.78). All participants signed a written informed consent prior to participating in the study. The study was approved by the Institutional Review Board of the University of Colorado, Boulder.
Data analysis
Data visualization was performed in MATLAB R2021b (The Mathworks, Inc). Multiple subjects did not complete the hour of wave-like motion due to reaching the stopping criteria of two minutes of moderate nausea. This yields a potentially biased sample among the surviving subjects in metrics such as MSQ and STAI. As a rudimentary adjustment for this, when a subject reached the stopping criteria, based upon their available data during wave-like motion we linearly extrapolated their responses (MSQ score, STAI score) for the later time points they did not complete. If a subject only had one data point during wave-like motion, the first recovery data point was used with the amount of time the subject experienced wave-like motion for the linear extrapolation (this only occurred for one of our 30 subjects). In these cases, extrapolated data points are specifically denoted (open shapes and dotted lines). To maintain robustness for this rough approximation, median values of MSQ and STAI were used for graphical visualization and non-parametric statistics were similarly employed. Statistical analyses were performed in both MATLAB and R 4.3.0 (RStudio 2023.03.0 + 386).
To investigate factors that may impact the MSQ subcategory scores, we created a series of cumulative link regression models that were fit with the ordinal scores at the wave + 55 time point. This point was selected because it is the last time point that contains extrapolated data for subjects that dropped out of the study and conservatively estimates the MSQ at the end of wave-like motion. The model parameters include MSSQ scores and experimental group. This allows for testing the effect of the countermeasure (relative to the control), while isolating inter-individual variability that could be explained by each individual’s MSSQ score.
Two more cumulative link models were developed to determine if there is a relationship between full MSQ scores and experimental group, MSSQ and STAI scores independently at two relevant time points. Based upon SpaceX’s Dragon landings to date, nominal capsule recovery is expected to take place approximately 30 min following splashdown with the final crewman removed from the capsule at 55 min following splashdown (Dervay 2023). Therefore, MSQ scores were fit with the model at both wave + 30 and wave + 55.
Results
For all 30 subjects, individual sickness and anxiety progressions during the wave-like motion were plotted with linear extrapolations for subjects that did not complete the full hour. The final full MSQ and STAI taken during wave-like motion were performed at time wave + 60 as the profile comes to a stop and the recovery period begins, labeled as recov + 0. For subjects with extrapolated data, the final full MSQ and STAI scores available were set as the recov + 0 data points.
MSQ scores
Full MSQ scores over time are shown in Fig. 4 (Fig. 4a depicts the time history of each subject in the control group, and Fig. 4b contains the visual countermeasure group). The median scores for both experimental groups along with the 25th and 75th percentiles are shown in Fig. 4c. Neither the median values nor the quartile bounds differ between the two experimental groups.
For the GI disturbance MSQ subcategory, there was a slight difference between the two experimental groups, as evidenced by Fig. 5a. While the quartile ranges overlapped the entire duration of the experiment, the median of the control group diverted from the visual countermeasure group at around wave + 30 resulting in slightly higher GI disturbance. This difference quickly disappeared during recovery as the scores converge.
The time course of MSQ sopite symptoms during wave-like motion and recovery are displayed in Fig. 5b. The scores did not vary between the experimental groups, but the development of sopite symptoms was different than the progression of MSQ GI symptoms. Unlike the divergence between experimental groups and the increase in the GI disturbance score at wave + 30, the sopite scores of both groups increased steadily from the beginning of wave-like motion.
Finally, the time course of MSQ ocular symptoms is shown in Fig. 5c. The values between the experimental groups were slightly different with the control group median being offset from the countermeasure group, but this difference was well within the 25–75 percentile bounds of each group.
For all three of the subcategories, neither the MSSQ percentile, nor the experimental group variable reached significance, but the closest was the effect of experimental group on the GI score (\(\Delta\) GI55 = 2.17, \(\beta\) = − 1.204, p = 0.073).
STAI
STAI scores are plotted similarly to the MSQ scores, with individual scores for each experimental group shown in Fig. 6a and Fig. 6b and median scores in Fig. 6c with the quartile ranges shown. Subjects in the control group have higher median STAI scores throughout the wave-like motion and have a larger spread of anxiety throughout recovery when compared to visual countermeasure group.
The cumulative link models found that the only significant factor in predicting MSQ scores is the STAI score at the same time point (wave + 30: z = 3.58, p = 0.00034; wave + 55: z = 3.65, p = 0.00026). Combining both time points, a Spearman Rank correlation test was run and found that there was a moderately high correlation between MSQ score and STAI score (\(\rho\) = 0.65, p < 0.0001), suggesting that physically unwell subjects also demonstrate higher amounts of state anxiety.
Nausea
During wave-like motion and recovery, subjects rated their general discomfort and nausea every minute. The high-resolution time course of these nausea ratings during the wave-like motion are shown in Fig. 7.
Subjects in the control group (Fig. 7a) tend to have a higher incidence of moderate motion sickness, as well as quicker development. Like the divergence shown in Fig. 5a at wave + 30, at the halfway point of wave-like motion, the rate of nausea development accelerates in control subjects while it otherwise remains fairly constant in the countermeasure group.
Survival
Subjects who expressed two consecutive reports of moderate nausea (i.e., separated by one minute) during wave-like motion were stopped early to prevent emesis during the experiment. Figure 8 shows the time course of percentage of subject survival between the two experimental groups. Only 33% (SE: ± 8.78%) of the control group (n = 5/15) was able to survive the full hour of wave-like motion. In contrast, 79% (SE: ± 6.44%) of the countermeasure group (n = 11/14) was able to complete the wave-like motion.
As expected, since this metric is directly related to nausea, we see the same divergence at wave + 30 where control group subjects demonstrate accelerated drop-out due to a faster onset of moderate nausea.
A logistic regression model was developed to determine the impact of experimental group and individual MSSQ on whether a subject would survive the full hour of wave-like motion. The model found that MSSQ did not have a significant effect on predicting subject survival (z = − 0.295, p = 0.768) while the experimental group did (z = 2.138, p = 0.0325). As any effect of the countermeasure could have confounded a relationship, we repeated this analysis within just the control group, but again found no association between MSSQ and surviving the wave-like motion (z(14) = − 0.731, p = 0.465). To follow up, a two-tailed t-test for proportions was used to directly compare the survival proportions between the two groups at wave + 60 and found a significantly higher survival rate in the visual countermeasure group than the control group (t(14) = 2.50, p = 0.027).
Balance
Two objective measurements were performed to assess balance throughout the experiment. The percentage of modified Romberg balance trials successfully completed at each stage of the experiment is shown in Fig. 9a, while the median off-axis sway is shown in Fig. 9b. For both metrics, it is important to note that subjects that reached the stopping criteria did not undergo a full hour of wave-like motion, and as a result, may not have experienced the same amount of imbalance as those that did. Since more control subjects dropped out than countermeasure subjects, this may introduce a bias in balance outcomes between the experimental groups.
Figure 9a shows that some subjects experienced balance decrements (i.e., lower pass percentage) after the wave-like motion relative to before the SIC protocol; however, the presence of a visual countermeasure does not seem to impact the number of successfully completed balance tasks. Additionally, regardless of experimental group, subjects were able to reach or improve their baseline performance by the end of an hour of recovery.
Figure 9b shows a similar trend to Fig. 9a in relation to the impact of SIC and wave-like motion on balance. Just as suggested by the pass percentages, which are imprecise measurements of balance, sway increases as a result of SIC and wave-like motion and improves upon or returns to baseline after an hour of recovery.
Wilcoxon Rank Sum tests of independent samples performed at each test stage found no significant differences between experimental groups (p > 0.05). Therefore, we combined the two experimental groups at each time point and ran a Friedman test for sway across test stages. Here we found that there was a significant relationship between sway and test stage (\({\chi }^{2}\left(2\right)\)=18.2, p = 0.0001). Post-hoc Wilcoxon Rank Sum tests with a Bonferroni correction concluded that only the difference between post-wave and post-recovery sway was significant (p = 0.0004), and the difference between pre-SIC and post-wave sway was marginally significant (p = 0.056).
Discussion
The purpose of this study was to determine if providing motion-congruent visual information via VR is an effective avenue for improving motion tolerability and reducing the incidence of motion sickness in astronauts during post-flight water landings. We used a ground-based reentry analog to mimic the subsequent effects of transitioning from microgravity to Earth gravity followed by wave-like motion. Half of our subjects were provided with visual cues of self-motion while the other half were provided with a head-fixed fixation point, both in a VR headset. Supporting our primary hypothesis, the countermeasure group had a significantly better survival rate after an hour of wave-like motion. Specifically, with the pre-defined stopping criteria of two consecutive reports of ‘moderate’ nausea (separated by one minute), more than twice as many subjects with the countermeasure completed the one hour of wave-like motion than the control group. Additionally, while we did not see any significant differences in multisymptomatic motion sickness (MSQ) scores between the visual and control groups, we did find significant evidence correlating MSQ and STAI scores as previously suggested in the literature (Lawson 2014a, b; Stelling et al. 2021). In investigating our secondary hypothesis, we detected no differences in sensorimotor performance between the countermeasure and control groups in terms of balance outcomes. However, both experimental groups saw significantly reduced balance performance following the centrifugation and wave-like motion, with inertial XY-plane RMS of linear acceleration (a proxy for sway) significantly higher during the post-wave stage than the post-recovery stage.
This experiment represents the first demonstration that reliable, motion-congruent visual cues of self-motion significantly reduce peak motion sickness symptom severity following an hour of wave-like motion preceded by a ground-based gravity transition analog. In contrast to previous studies that have investigated the efficacy of an artificial horizon (Krueger 2011), this is the first instance in which a visually rich scene providing cues of both tilt and translation has been used. The evidence found—that this visual countermeasure can more effectively bound motion sickness symptoms at and beneath moderate nausea (i.e., increase survivability) than the control—suggests that providing crewmembers similar, motion-congruent visual cues may be an effective avenue of curbing the onset of more severe motion sickness symptoms. Thus, providing either natural or synthetic Earth-veridical visual information may both reduce operational risks (such as vehicle egress) and discomfort following landing, providing crewmembers and commercial space travelers more tolerable experiences. Additionally, this visual countermeasure may be beneficial during future exploration class missions (e.g., landing on the moon or Mars), where crewmembers will not have access to astronaut rehabilitation specialists for support post-landing (S. J. Wood et al. 2011).
While sensory conflict theory provides insight into reducing motion sickness using congruent visual scenes, the conflict would not necessarily be fully eliminated with this methodology. Future computational models of motion sickness, with the capability of modeling motion sickness in the presence of arbitrary motions and arbitrary visual scenes, may enable the construction of visual scenes that result in additional attenuation of motion sickness symptoms. To this end, we anticipate that the individual subject responses provided in this effort may be utilized to inform future computational modeling efforts, provided that neurovestibular changes during the ~ 1 h of SIC, passive motions during the wave-like motion, and visual channels during wave-like motion are all sufficiently modeled.
Additionally, we provide a quantification of sensorimotor impairment and the resultant time course of adaptation (sway, captured during a vestibular-mediated modified Romberg test) following our SIC protocol. While we did not see a difference in sway between experimental groups, the finding that sway is significantly higher following wave-like motion (preceded by SIC) than after recovery provides some time course for the effectiveness of this analog at inducing sensorimotor impairment for use in future studies (i.e., for future use as an impairment paradigm). Furthermore, we suspect that our marginally significant finding between the pre-SIC and post-Wave stages may be confounded with an ordering effect since the pre-SIC balance tests served as practice before the post-wave tests. We likely would have found a significant difference between these two stages if subjects were given practice trials prior to data collection. It is important to note that these results are impacted by the presence of wave-like motion, which may have induced some level of postural instability or recovery.
Limitations
This study is limited by the paradigms leveraged in this study. We have leveraged the SIC paradigm as an analog to gravity transitions, but actual sensory reinterpretation of Earth gravity cues following a prolonged stint in microgravity will likely result in different time courses of both readaptation and motion sickness symptoms. Additionally, there is high inter-subject variability in susceptibility to the SIC paradigm that cannot be captured by the MSSQ or any other metric presently. This may have resulted in an unaccounted group difference, though MSQ scores prior to wave-like motion did not differ significantly between groups. Moreover, our TTS device was not capable of providing representative Earth-vertical motions experienced by a capsule following splashdown (referred to as heave), which have been found to induce motion sickness for certain frequencies of motion in a cabin environment (O’Hanlon & McCauley 1973). To help address the impact of these analog paradigms, a manuscript on a companion study using alternative gravity transition and sea state exposure with the same countermeasure approach is forthcoming.
Additionally, astronauts returning to Earth after prolonged stays in microgravity are thought to undergo a level of sensory reweighting (Fetsch et al. 2009; Hupfeld et al. 2022) unlikely replicated by our relatively short-duration analog. This reweighting results in an increased reliance on visual information and a decreased reliance on vestibular information, as well as an increased reliance in somatosensory cues. For this reason, we postulate that an operational implementation of our visual countermeasure may result in more efficacy, due to the increased reliance on visual information following splashdown.
Finally, this study is limited by the conveniences afforded by the laboratory setting. We were able to provide motion-congruent visual sensory information to subjects because we knew the wave motion profile ex-ante. In practice, supplying subjects with a visual scene will likely only be possible with some time-lag following actual motion, and such a lag was not present during our experiment. If future implementations of the visual countermeasure are found to have a significant time-lag, it will likely be worth reexamining the efficacy of this visual countermeasure with a lag or considering different methods of implementation. Hock et al. 2017 created an IMU-driven VR environment that enabled car passengers to play a VR game with less motion sickness while driving than when stationary. They used a linear interpolation of speed and rotation to remove lag suggesting that a similar implementation of our visual scene may be able to use the same process (Hock et al. 2017).
Future work
The current study investigated the efficacy of providing a rich visual scene with motion-congruent cues in VR, as compared to only showing a fixation point in VR. Future work should elucidate the role of (1) the visual modality (e.g., VR, external display, natural vision), (2) the rich visual scene vs. simple cues of self-motion (e.g., an artificial horizon line), and (3) the fixation point control condition (which likely suppresses the vestibulo-ocular reflex) vs. a completely dark scene or with eyes closed.
Additional avenues of alleviating symptom severity through non-pharmaceutical means should be explored. Previously in the literature, while examining the development of motion sickness due to horizontal oscillations, symptoms have been found to be affected by the level of back support provided to subjects, while in an upright seating configuration (Mills and Griffin 2000). Future experiments should additionally explore how active postural control influences the development of symptoms and if active postural control can be strategically implemented to reduce symptom severity, using a combination of the entry motion sickness paradigm and visual countermeasure presented in this effort.
Data availability
Additional datasets generated during and/or analyzed during the current study are available on Open Science Framework (OSF) at the following link: https://osf.io/cb4fk/?view_only=c8177c3d215c470c86efe2b5c9e39cc3.
References
Agrawal Y, Carey JP, Hoffman HJ, Sklare DA, Schubert MC (2011) The modified romberg balance test: normative data in U.S. Adults. Otology & Neurotology 32(8):1309. https://doi.org/10.1097/MAO.0b013e31822e5bee
Albery WB, Martin ET (1996) Development of space motion sickness in a ground-based human centrifuge. Acta Astronaut 38(9):721–731. https://doi.org/10.1016/0094-5765(96)00011-2
Allred AR, Kravets VG, Ahmed N, Clark TK (2023) Modeling orientation perception adaptation to altered gravity environments with memory of past sensorimotor states. Frontiers in Neural Circuits 17:1190582. https://doi.org/10.3389/fncir.2023.1190582
Bagian JP (1991) First intramuscular administration in the U.S. Space program. J Clin Pharmacol 31(10):920. https://doi.org/10.1002/j.1552-4604.1991.tb03649.x
Bagian JP, Ward DF (1994) A retrospective study of promethazine and its failure to produce the expected incidence of sedation during space flight. J Clin Pharmacol 34(6):649–651. https://doi.org/10.1002/j.1552-4604.1994.tb02019.x
Beltran, N. E., Bollinger, A., Duplechin, R., Wang, Z., Daniels, V. R., Reschke, M. F., & Wood, S. J. (2022). Optimizing the Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-Transition Induced Motion Sickness and Enhance Sensorimotor Performance. Human Research Program Investigators’ Workshop. https://ntrs.nasa.gov/citations/20220001874
Bermúdez Rey MC, Clark TK, Merfeld DM (2017) Balance screening of vestibular function in subjects aged 4 years and older: a living laboratory experience. Front Neurol. https://doi.org/10.3389/fneur.2017.00631
Bles W, de Graaf B (1993) Postural consequences of long duration centrifugation. J Vestibular Res Equilibrium Orientation https://www.semanticscholar.org/paper/Postural-consequences-of-long-duration-Bles-Graaf/2a3ea3861b6e5cc10d9720e269e390f31d6269e5
Bles W, Graaf B de , Bos JE (1996) Space adaptation syndrome (SAS) and sickness induced by centrifugation (SIC): Vestibular consequences of earth anomalous gravity. J Vestib Res 4 Supplement 1; S(6), S66
Bles W, de Graaf B, Bos JE, Groen E, Krol JR (1997) A sustained hyper-g load as a tool to simulate space sickness. J Gravit Physiol 4(2):1–4
Bos JE, MacKinnon SN, Patterson A (2005) Motion sickness symptoms in a ship motion simulator. Effects Inside Outside No View 76(12):8
Bos JE, Diels C, Souman JL (2022) Beyond seasickness: a motivated call for a new motion sickness standard across motion environments. Vibration. https://doi.org/10.3390/vibration5040044
Bretl KN, Clark TK (2020) Improved feasibility of astronaut short-radius artificial gravity through a 50-day incremental, personalized, vestibular acclimation protocol. Npj Microgravity. https://doi.org/10.1038/s41526-020-00112-w
Bretl KN, Clark TK (2022) Predicting individual acclimation to the cross-coupled illusion for artificial gravity. J Vestib Res 32(4):305–316. https://doi.org/10.3233/VES-210019
Bretl KN, McCusker AT, Sherman SO, Mitchell TR, Dixon JB, Clark TK (2019) Tolerable acclimation to the cross-coupled illusion through a 10-day, incremental, personalized protocol. J Vestibular Res Equilib Orientat 29(2/3):97–110. https://doi.org/10.3233/VES-190656
Cha Y-H, Golding JF, Keshavarz B, Furman J, Kim J-S, Lopez-Escamez JA, Magnusson M, Yates BJ, Lawson BD (2021) Motion sickness diagnostic criteria: consensus document of the classification committee of the Bárány society. J Vestib Res 31(5):327–344. https://doi.org/10.3233/VES-200005
Clément GR, Boyle RD, George KA, Nelson GA, Reschke MF, Williams TJ, Paloski WH (2020) Challenges to the central nervous system during human spaceflight missions to Mars. J Neurophysiol 123(5):2037–2063. https://doi.org/10.1152/jn.00476.2019
Cowings PS, Toscano WB, DeRoshia C, Miller NE (2000) Promethazine as a motion sickness treatment: impact on human performance and mood states. Aviat Space Environ Med 71(10):1013–1022
Davis JR, Jennings RT, Beck BG (1993a) Comparison of treatment strategies for space motion sickness. Acta Astronaut 29(8):587–591. https://doi.org/10.1016/0094-5765(93)90074-7
Davis JR, Jennings RT, Beck BG, Bagian JP (1993b) Treatment efficacy of intramuscular promethazine for space motion sickness. Aviat Space Environ Med 64(3 Pt 1):230–233
Davis S, Nesbitt K, Nalivaiko E (2014) A systematic review of cybersickness. Proc Conf Interactive Entertain. https://doi.org/10.1145/26777582677780
Dervay, J. (2023). NASA Commercial Crew Program and Medical Operational Challenges. 2023 Aerospace Medical Association Conference.
Fetsch CR, Turner AH, DeAngelis GC, Angelaki DE (2009) Dynamic reweighting of visual and vestibular cues during self-motion perception. J Neurosci 29(49):15601–15612. https://doi.org/10.1523/JNEUROSCI.2574-09.2009
Golding JF (1998) Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness. Brain Res Bull 47(5):507–516. https://doi.org/10.1016/S0361-9230(98)00091-4
Golding JF (2006) Predicting individual differences in motion sickness susceptibility by questionnaire. Personality Individ Differ 41(2):237–248. https://doi.org/10.1016/j.paid.2006.01.012
Golding JF, Paillard AC, Normand H, Besnard S, Denise P (2017) Prevalence, predictors, and prevention of motion sickness in zero-G parabolic flights. Aerospace Med Hum Perform 88(1):3–9. https://doi.org/10.3357/AMHP.4705.2017
Gorgiladze GI, Brianov II (1989) Space motion sickness. Kosm Biol Aviakosm Med 23(3):4–14
Graybiel A, Knepton J (1976) Sopite syndrome: a sometimes sole manifestation of motion sickness. Aviat Space Environ Med 47(8):873–882
Graybiel A, Lackner JR (1987) Treatment of severe motion sickness with antimotion sickness drug injections. Aviat Space Environ Med 58(8):773–776
Griffin MJ, Newman MM (2004) Visual field effects on motion sickness in cars. Aviat Space Environ Med 75(9):10
Groen E, de Graaf B, Bles W, Bos JE (1996) Ocular torsion before and after 1 hour centrifugation. Brain Res Bull 40(5):331–333. https://doi.org/10.1016/0361-9230(96)00125-6
Gupta AK, Kumar BV, Rajguru R, Parate K (2021) Assessment of sea sickness in naval personnel: incidence and management. Ind J Occup Environ Med 25(2):119–124. https://doi.org/10.4103/ijoem.IJOEM_94_20
Heer M, Paloski WH (2006) Space motion sickness: incidence, etiology, and countermeasures. Auton Neurosci 129(1):77–79. https://doi.org/10.1016/j.autneu.2006.07.014
Héroux ME, Law TCY, Fitzpatrick RC, Blouin J-S (2015) Cross-modal calibration of vestibular afference for human balance. PLoS ONE 10(4):e0124532. https://doi.org/10.1371/journal.pone.0124532
Hock, P., Benedikter, S., Gugenheimer, J., & Rukzio, E. (2017). CarVR: Enabling In-Car Virtual Reality Entertainment. Proceedings of the 2017 CHI Conference on Human Factors in Computing Systems, 4034–4044. https://doi.org/10.1145/3025453.3025665
Hupfeld KE, McGregor HR, Koppelmans V, Beltran NE, Kofman IS, De Dios YE, Riascos RF, Reuter-Lorenz PA, Wood SJ, Bloomberg JJ, Mulavara AP, Seidler RD (2022) Brain and behavioral evidence for reweighting of vestibular inputs with long-duration spaceflight. Cereb Cortex 32(4):755–769. https://doi.org/10.1093/cercor/bhab239
Irmak T, de Winkel KN, Pool DM, Bülthoff HH, Happee R (2021) Individual motion perception parameters and motion sickness frequency sensitivity in fore-aft motion. Exp Brain Res 239(6):1727–1745. https://doi.org/10.1007/s00221-021-06093-w
Kennedy RS, Lane NE, Berbaum KS, Lilienthal MG (1993) Simulator sickness questionnaire: an enhanced method for quantifying simulator sickness. Int J Aviat Psychol 3(3):203. https://doi.org/10.1207/s15327108ijap0303_3
Kravets VG, Dixon JB, Ahmed NR, Clark TK (2021) COMPASS: computations for orientation and motion perception in altered sensorimotor states. Frontiers in Neural Circuits. https://doi.org/10.3389/fncir.2021.757817
Krueger WWO (2011) Controlling motion sickness and spatial disorientation and enhancing vestibular rehabilitation with a user-worn see-through display. Laryngoscope 121(S2):S17–S35. https://doi.org/10.1002/lary.21373
Lackner JR (2014) Motion sickness: More than nausea and vomiting. Exp Brain Res 232(8):2493–2510. https://doi.org/10.1007/s00221-014-4008-8
Lackner JR, DiZio P (2006) Space motion sickness. Exp Brain Res 175(3):377–399. https://doi.org/10.1007/s00221-006-0697-y
Lackner JR, Graybiel A (1987) Head movements in low and high gravitoinertial force environments elicit motion sickness: implications for space motion sickness. Aviat Space Environ Med 58(9 Pt 2):A212–A217
Lawson BD, Mead AM (1998) The sopite syndrome revisited: drowsiness and mood changes during real or apparent motion. Acta Astronaut 43(3):181–192. https://doi.org/10.1016/S0094-5765(98)00153-2
Lawson, B. (2014). Motion Sickness Symptomatology and Origins (pp. 531–600). https://doi.org/10.1201/b17360-29
Lawson, B. D. (2014). Chapter 24. Motion Sickness Scaling.
Lee SMC, Ribeiro LC, Laurie SS, Feiveson AH, Kitov VV, Kofman IS, Macias BR, Rosenberg M, Rukavishnikov IV, Tomilovskaya ES, Bloomberg JJ, Kozlovskaya IB, Reschke MF, Stenger MB (2020) Efficacy of gradient compression garments in the hours after long-duration spaceflight. Front Physiol. https://doi.org/10.3389/fphys.2020.00784
Lucot JB (1998) Pharmacology of motion sickness. J Vestib Res 8(1):61–66. https://doi.org/10.3233/VES-1998-8109
Marteau TM, Bekker H (1992) The development of a six-item short-form of the state scale of the spielberger state—trait anxiety inventory (STAI). Br J Clin Psychol 31(3):301–306. https://doi.org/10.1111/j.2044-8260.1992.tb00997.x
Mills KL, Griffin MJ (2000) Effect of seating, vision and direction of horizontal oscillation on motion sickness. Aviat Space Environ Med 71:996–1002
Nooij SAE, Bos JE (2007) Sickness induced by head movements after different centrifugal Gx-loads and durations. J Vestib Res 17(5–6):323–332. https://doi.org/10.3233/VES-2007-175-612
Nooij SAE, Bos JE, Groen EL, Bles W, Ockels WJ (2007) Space sickness on earth. Microgravit Sci Technol 19(5):113–117. https://doi.org/10.1007/BF02919464
Nooij SAE, Bos JE, Groen EL (2008) Orientation of listing’s plane after hypergravity in humans. J Vestib Res 18(2–3):97–105. https://doi.org/10.3233/VES-2008-182-303
Nooij, S. A. E., Le Mair, A. F., Bos, J. E., & Groen, E. L. (2005). Vestibular adaptation to changing gravity levels and orientation of Listing’s plane. 585, 61
O’Hanlon, J. F., & McCauley, M. E. (1973). Motion sickness incidence as a function of the frequency and acceleration of vertical sinusoidal motion. CANYON RESEARCH GROUP INC GOLETA CA HUMAN FACTORS RESEARCH DIV.
Ockels WJ, Furrer R, Messerschmid E (1990) Simulation of space adaptation syndrome on earth. Exp Brain Res 79(3):661–663. https://doi.org/10.1007/BF00229334
Oman CM (1982) A heuristic mathematical model for the dynamics of sensory conflict and motion sickness. Acta Otolaryngol 94(sup392):4–44. https://doi.org/10.3109/00016488209108197
Oman CM (1990) Motion sickness: a synthesis and evaluation of the sensory conflict theory. Can J Physiol Pharmacol 68(2):294–303. https://doi.org/10.1139/y90-044
Oman CM, Cullen KE (2014) Brainstem processing of vestibular sensory exafference: implications for motion sickness etiology. Exp Brain Res 10:2492
Ortega HJ, Harm DL, Reschke MF (2019) Space and entry motion sickness. In: Barratt MR, Baker ES, Pool SL (eds) Principles of clinical medicine for space flight. Springer New York, New York, pp 441–456. https://doi.org/10.1007/978-1-4939-9889-0_14
Pechenkova E, Nosikova I, Rumshiskaya A, Litvinova L, Rukavishnikov I, Mershina E, Sinitsyn V, Van Ombergen A, Jeurissen B, Jillings S, Laureys S, Sijbers J, Grishin A, Chernikova L, Naumov I, Kornilova L, Wuyts FL, Tomilovskaya E, Kozlovskaya I (2019) Alterations of functional brain connectivity after long-duration spaceflight as revealed by fMRI. Front Physiol. https://doi.org/10.3389/fphys.2019.00761
Perrin P, Lion A, Bosser G, Gauchard G, Meistelman C (2013) Motion sickness in rally car co-drivers. Aviat Space Environ Med 84(5):473–477. https://doi.org/10.3357/ASEM.3523.2013
Reason JT, Brand JJ (1975) Motion sickness. Academic Press, Cambridge, pp vii–310
Schmidt EA, Kuiper OX, Wolter S, Diels C, Bos JE (2020) An international survey on the incidence and modulating factors of carsickness. Transport Res f: Traffic Psychol Behav 71:76–87. https://doi.org/10.1016/j.trf.2020.03.012
Stelling D, Hermes M, Huelmann G, Mittelstädt J, Niedermeier D, Schudlik K, Duda H (2021) Individual differences in the temporal progression of motion sickness and anxiety: the role of passengers’ trait anxiety and motion sickness history. Ergonomics 64(8):1062–1071. https://doi.org/10.1080/00140139.2021.1886334
Stoffregen TA, Chen F-C, Varlet M, Alcantara C, Bardy BG (2013) Getting your sea legs. PLoS ONE 8(6):e66949. https://doi.org/10.1371/journal.pone.0066949
Thornton WE, Bonato F (2013) Space motion sickness and motion sickness: symptoms and etiology. Aviat Space Environ Med 84(7):716–721. https://doi.org/10.3357/ASEM.3449.2013
Turner M (1999) Motion sickness in public road transport: passenger behaviour and susceptibility. Ergonomics 42(3):444–461. https://doi.org/10.1080/001401399185586
Wood CD, Stewart JJ, Wood MJ, Manno JE, Manno BR, Mims ME (1990) Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness. Aviat Space Environ Med 61(2):157–161
Wood SJ, Loehr JA, Guilliams ME (2011) Sensorimotor reconditioning during and after spaceflight. Neuro Rehabilit 29(2):185–195. https://doi.org/10.3233/NRE-2011-0694
Funding
This work was supported by the National Aeronautics and Space Administration Human Research Program under Grant No. 80NSSC21K0257. Additionally, this work was supported by a NASA Space Technology Graduate Research Opportunities Award.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The studies involving human participants were reviewed and approved by The Institutional Review Board at the University of Colorado Boulder. The subjects/participants provided their written informed consent to participate in this study.
Additional information
Communicated by Bill J Yates.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The views expressed are those of the authors and do not necessarily reflect the views of the sponsoring organization nor the official policy or position of the Department of the Navy, Department of Defense (DoD), nor the U.S. Government. Dr. Lawson is an employee of the U.S. Government. This work was prepared as part of his official duties. Title 17 U.S.C. §105 provides that ‘Copyright protection under this title is not available for any work of the United States Government.’
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lonner, T.L., Allred, A.R., Bonarrigo, L. et al. Virtual reality as a countermeasure for astronaut motion sickness during simulated post-flight water landings. Exp Brain Res 241, 2669–2682 (2023). https://doi.org/10.1007/s00221-023-06715-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00221-023-06715-5